Published: 2020-10-28

Pulmonary pleomorphic carcinoma masquerading as pulmonary tuberculosis: incidental autopsy finding

Teerthanath Srinivas, Shreya Goel, Shubha P. Bhat, Ritu Asnani


Pleomorphic carcinoma is a very rare subtype of pulmonary sarcomatoid carcinoma. It is an aggressive primary lung carcinoma that accounts for about <0.4% of lung tumors. The tumor usually recurs, resulting in a poor prognosis even after complete resection. Herein, we report an extremely rare case of an advanced pleomorphic carcinoma of the lung which was incidentally detected on autopsy as pulmonary tuberculosis. This patient did not have any clinical manifestations of either malignancy or tuberculosis when he was alive. This is extremely rare, being it an aggressive carcinoma that presents without any apparent symptoms.


Pleomorphic carcinoma, Autopsy, Incidental, Smoking

Full Text:



Mirza R, Shi M. Large pleomorphic carcinoma of the lung Human Pathology. Cas Repor. 2019;16:1-4.

Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68:7-30.

Zhang X, Wang Y, Zhao L, Jing H, Sang S, Du J. Pulmonary pleomorphic carcinoma: A case report and review of the literature. Medic. 2017;96(29):e7465.

Rahouma M, Kamel M, Narula N, Nasar A, Harrison S, Lee B et al. Pulmonary sarcomatoid carcinoma: an analysis of a rare cancer from the surveillance, epidemiology, and end results database. Eur J Cardiothorac Surg. 2018;53:828-34.

Blaukovitsch M, Halbwedl I, Kothmaier H, Kammerer MG, Popper HH et al. Sarcomatoid carcinomas of the lung—are these histogenetically heterogeneous tumors. Virchows Arch. 2006;449(4):455-61.

Mochizuki T, Ishii G, Nagai K, Yoshida J, Nishimura M, Mizuno T et al. Pleomorphic carcinoma of the lung: Clinicopathologic characteristics of 70 cases. Am J Surg Pathol. 2008;32(11):1727-35.

Anter AH, Al-Jahel M, AbdelLatif RM, AbdELmohsen MF, Shata A. Pulmonary pleomorphic carcinoma harboring epidermal growth factor receptor mutation: Response to afatinib. J Cancer Res Pract. 2019;6:103-6.

Fujisaki A, Aoki T, Kasai T, Kinoshita S, Tomoda Y, Fumihiro T et al. Pleomorphic Carcinoma of the Lung: Relationship Between CT Findings and Prognosis. AJR Am J Roentgenol. 2016;207(2):289-94.

Kim TS, Han J, Lee KS, Jeong JY, Kwak SH, Byun HS et al. CT findings of surgically resected pleomorphic carcinoma of the lung in 30 patients. AJR Am J Roentgenol. 2005;185(1):120-5.

Kim MJ, Lee HN, Kim JI, Kim GY. Pleomorphic carcinoma of the lung mimicking synchronous pulmonary adenocarcinoma and small bowel sarcoma. Ann Thorac Med. 2018;13(4):251-3.

Roesel C, Terjung S, Weinreich G, Hager T, Chalvatzoulis E, Metzenmacher M et al. Sarcomatoid carcinoma of the lung: a rare histological subtype of nonsmall cell carcinoma with a poor prognosis even at earlier tumor stages, Interact Cardiovasc Thorac Surg. 2017;24(3):407-13.

Lui NS. Commentary: Pleomorphic carcinoma: An aggressive type of non-small cell lung cancer that should be treated like the others. J Thorac Cardiovasc Surg. 2019;158(2):592-3.

Tamura Y, Fujiwara Y, Yamamoto N, Nokihara H, Horinouchi H, Kanda S. et al. Retrospective analysis of the efficacy of chemotherapy and molecular targeted therapy for advanced pulmonary pleomorphic carcinoma. Brit Med Cen Res Notes. 2015;8:800.

Asamura H, Goya T, Koshiishi Y, Sohara Y, Eguchi K, Mori M et al. A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers. J Thorac Oncol. 2008;3:46-52.

Kaira K, Horie Y, Ayabe E, Murakami H, Takahashi T, Tsuya A et al. Pulmonary pleomorphic carcinoma: a clinicopathological study including EGFR mutation analysis. J Thorac Oncol. 2010;5(4):460-5.

Ushiki A, Koizumi T, Kobayashi N, Kanda S, Yasuo M, Yamamoto H et al. Genetic heterogeneity of EGFR mutation in pleomorphic carcinoma of the lung: response to gefitinib and clinical outcome. Jpn J Clin Oncol. 2009;39(4):267-70.

Chang YL, Lee YC, Shih JY, Wu CT. Pulmonary pleomorphic (spindle) cell carcinoma: peculiar clinicopathologic manifestations different from ordinary non-small cell carcinoma. Lun Canc. 2001;34:91–7.